dailymindgrind.wordpress.com
Psychedelic Drugs Hold Medical Promise: A Summary
The DEA and the U.S. Food and Drug Administration maintain that there is insufficient research to justify recategorization from Schedule I. This stance creates a catch-22 by basing the decision on …